Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 66 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 7585841

    Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  2. US 7585667

    Negative strand RNA virus replicon

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  3. US 7576050

    GLP-1 exendin-4 peptide analogs and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted

  4. US 7572887

    Gene expressed in prostate cancer, methods and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  5. US 7572771

    Multi-domain amphipathic helical peptides and methods of their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  6. US 7569673

    Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  7. US 7566451

    Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  8. US 7560118

    Attenuated dengue virus comprising mutations in the NS3 gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

  9. US 7547773

    Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  10. US 7547762

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  11. US 7544789

    DNA encoding Toxoplasma gondii rDGP5p protein

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  12. US 7541043

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  13. US 7541139

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  14. US 7541034

    Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  15. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as represented by the Department of Health and Human Services · Granted May 26, 2009 · Expires May 21, 2029

    granted

  16. US 7534565

    DLC-1 gene deleted in cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted May 19, 2009 · Expires May 14, 2029

    granted

  17. US 7531352

    Inducible plasmid vector encoding TGF-β and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 12, 2009 · Expires May 7, 2029

    granted

  18. US 7528274

    Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The United States of America, as represented by the Department of Health and Human Services · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  19. US 7524508

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  20. US 7521063

    Multiple CPG oligodeoxynucleotides and their use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  21. US 7521479

    Methods of treating prion disease in mammals

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  22. US 7521177

    Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  23. US 7521475

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  24. US 7521054

    Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.